Steroid myopathy: Pathogenesis and effects of growth hormone and insulin-like growth factor-I administration

Hormone Research

Volumn 56, Issue SUPPL. 1, 2001, Pages 24-28

  Kanda, Fumio ^a   Okuda, Shiho ^a   Matsushita, Tatsuo ^a   Takatani, Keiko ^a   Kimura, Ken Ichi ^a   Chihara, Kazuo ^a  

^a KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Calcineurin; Glutamine synthetase; Growth hormone; Insulin like growth factor I; Steroid myopathy

Indexed keywords

CYCLOSPORIN A; DEXAMETHASONE; GLUCOCORTICOID; GLUTAMATE AMMONIA LIGASE; GLYCOGEN; GROWTH HORMONE; HYDROCORTISONE; MITOGEN ACTIVATED PROTEIN KINASE; PREDNISOLONE; SOMATOMEDIN C; STEROID; TRANSCRIPTION FACTOR GATA 2; TRIAMCINOLONE;

CLINICAL FEATURE; CONFERENCE PAPER; CORTICOSTEROID INDUCED MYOPATHY; CREATININE URINE LEVEL; DRUG EFFECT; DRUG EFFICACY; ENZYME ACTIVITY; GLYCOGEN MUSCLE LEVEL; HUMAN; MUSCLE ATROPHY; MUSCLE BIOPSY; MUSCLE WEAKNESS; MYOPATHY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKELETAL MUSCLE;

ANIMALS; GLUCOCORTICOIDS; GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MUSCULAR DISEASES; RECOMBINANT PROTEINS;

EID: 0035688774     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000048130     Document Type: Conference Paper

References (59)

1. Acute steroid-induced tetraplegia following status asthmaticus
2. Myopathy with thick filament (myosin) loss following prolonged paralysis with vecuronium during steroid treatment
3. Acute necrotizing myopathy of intensive care: Electrophysiologic studies
4. Steroid myopathy in connective tissue disease
5. Steroid myopathy in cancer patients
6. The endocrine myopathies
7. Experimental corticosteroid myopathy
8. Evidence that prednisone-induced myopathy is reversed by physical training
9. Muscle glycogen metabolism in steroid-induced myopathy of rabbits
10. Patients with chronic glucocorticoid treatment develop changes in muscle glycogen metabolism
11. Protein and amino acid metabolism in human muscle
12. Regulation of glutamine synthetase and glutaminase activities in cultured skeletal muscle cells
13. Dexamethasone regulates glutamine synthetase expression in rat skeletal muscles
14. Exogenous but not endogenous, glucocorticoid receptor induces glutamine synthetase gene expression in early stage embryonic retina
15. Identification of glucocorticoid-responsive elements that control transcription of rat glutamine synthetase
16. Glutamine synthetase expression in muscle is regulated by transcriptional and posttranscriptional mechanisms
17. Glutamine prevents downregulation of myosin heavy chain synthesis and muscle atrophy from glucocorticoids
18. Effects of growth hormone on skeletal muscle. I. Studies on normal adult rats
19. Supplemental growth hormone alters body composition, muscle protein metabolism and serum lipids in fit adults: Characterization of dose-dependent and response-recovery effects
20. Production of both prolactin and growth hormone by clonal strains of rat pituitary tumor cells. Differential effects of hydrocortisone and tissue extracts
21. Skeletal muscle hypertrophy in rats having growth hormone-secreting tumor
22. Effect of excessive secretion of growth hormone on tissues of the rat, with particular reference to the heart and skeletal muscle
23. Increased mortality associated with growth hormone treatment in critically ill adults
24. The effect of recombinant human growth hormone on malnourished older individuals
25. Effects of growth hormone on diaphragmatic recovery from malnutrition
26. Growth hormone stimulates protein synthesis during hypocaloric parenteral nutrition. Role of hormonal-substrate environment
27. Growth hormone and insulin reverse net whole body and skeletal muscle protein catabolism in cancer patients
28. Effects of growth hormone on skeletal muscle. II. Studies on regeneration and denervation in adult rats
29. Human growth hormone prevents the protein catabolic side effects of prednisone in humans
30. Growth hormone prevents steroid-induced growth depression in health and uremia
31. Growth hormone prevents the steroid myopathy in rats
32. Modification of glucocorticoid-induced changes in myofibrillar protein turnover in rats by protein and energy deficiency as assessed by urinary excretion of Ntau-methylhistidine
33. Growth hormone and the insulin-like growth factor system in myogenesis
34. Human growth hormone but not insulin-like growth factor I positively affects whole-body estimates of protein metabolism
35. Insulin-like growth factor I and growth hormone (GH) treatment in GH-deficient humans: Differential effects on protein, glucose, lipid, calcium metabolism
36. Growth hormone acutely stimulates forearm muscle protein synthesis in normal humans
37. Insulin and IGF-I induce pronounced hypertrophy of skeletal myofibers in tissue culture
38. Effect of insulin-like growth factor I in murine muscular dystrophy
39. Viral mediated expression of insulin-like growth factor I blocks the aging-related loss of skeletal muscle function
40. Insulin-like growth factor-I (IGF-I) and especially IGF-I variants are anabolic in dexamethasone-treated rats
41. Preventive effects of insulin-like growth factor-I on steroid-induced muscle atrophy
42. Insulin-like growth factor-I stimulates terminal myogenic differentiation by induction of myogenin gene expression
43. IGF-I restores satellite cell proliferative potential in immobilized old skeletal muscle
44. Mice carrying null mutations of the genes encoding insulin-like growth factors I (Igf-1) and type 1 IGF receptor (Igf1r)
45. Influences of IGF-I gene disruption of the cellular profile of the diaphragm
46. Exercise inhibits glucocorticoid-induced glutamine synthetase expression in rat skeletal muscles
47. Exercise interrupts ongoing glucocorticoid-induced muscle atrophy and glutamine synthetase induction
48. Growth hormone decreases muscle glutamine production and stimulates protein synthesis in hypercatabolic patients
49. The effects of growth hormone and insulin-like growth factors I and II on glutamine metabolism by skeletal muscle of the rat in vitro
50. Insulin-like growth factor 1 inhibits glucocorticoid-induced glutamine synthetase activity in cultured L6 rat skeletal muscle cells
51. The mitogenic and myogenic actions of insulin-like growth factors utilize distinct signaling pathways
52. Calcineurin activity is required for the initiation of skeletal muscle differentiation
53. A calcineurin-NFATc3-dependent pathway regulates skeletal muscle differentiation and slow myosin heavy-chain expression
54. A calcineurin-dependent transcriptional pathway controls skeletal muscle fiber type
55. Calcineurin is required for skeletal muscle hypertrophy
56. 2+-dependent calcineurin signaling pathway
57. IGF-1 induces skeletal muscle hypertrophy through calcineurin in association with GATA-2 and NF-ATc1
58. Insulin-like growth factors require phosphatidylinositol 3-kinase to signal myogenesis: Dominant negative p85 expression blocks differentiation of L6E9 muscle cells
59. Dexamethasone inhibits insulin-like growth factor signaling and potentiates myoblast apoptosis